Skip to main content

Table 3 Swedish universities Scales of Personality (SSP) raw scores (mean [standard deviation]) and 95% confidence interval (CI) of the difference between baseline and follow-up in patients with psychotic illness and non-psychotic controls

From: Stability of personality traits over a five-year period in Swedish patients with schizophrenia spectrum disorder and non-psychotic individuals: a study using the Swedish universities scales of personality

   

Somatic Trait Anxiety

Psychic Trait Anxiety

Stress Susceptibility

  

N

Baseline

Follow-up

CI

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

36

39.4 (7.7)

44.4 (7.8)

−0.25 – 0.15

2.08 (0.48)

2.13 (0.53)

−0.09 – 0.27

2.45 (0.62)

2.36 (0.61)

−0.19 – 0.16

 

Control

76

41.1 (7.8)

47.5 (7.8)

−0.06 – 0.12

1.58 (0.46)

1.55 (0.45)

0.11–0.26

1.66 (0.50)

1.48 (0.39)

−0.05 – 0.14

ALL

Men

75

40.7 (7.9)

46.5 (8.0)

−0.14 – 0.08

1.68 (0.48)

1.71 (0.56)

0.04–0.22

1.92 (0.68)

1.79 (0.66)

−0.06 – 0.14

 

Women

37

40.1 (7.7)

46.4 (7.9)

−0.08 – 0.21

1.74 (0.52)

1.78 (0.53)

0.07–0.34

1.90 (0.60)

1.70 (0.55)

−0.17 – 0.16

PATIENT

Men

28

39.9 (7.5)

44.9 (7.6)

−0.39 – 0.09

2.05 (0.39)

2.19 (0.51)

−0.17 – 0.24

2.47 (0.60)

2.43 (0.52)

−0.24 – 0.17

 

Women

8

37.5 (8.2)

42.6 (8.2)

0.02–0.55

2.21 (0.71)

1.93 (0.57)

−0.17 – 0.74

2.38 (0.71)

2.09 (0.84)

−0.40 – 0.51

CONTROL

Men

47

41.2 (8.1)

47.5 (8.0)

−0.06 – 0.14

1.47 (0.39)

1.43 (0.36)

0.10–0.28

1.60 (0.49)

1.41 (0.37)

−0.02 – 0.20

 

Women

29

40.8 (7.4)

47.5 (7.5)

−0.16 – 0.18

1.75 (0.71)

1.74 (0.52)

0.04–0.33

1.77 (0.51)

1.59 (0.40)

−0.21 – 0.17

  

Lack of Assertiveness

Impulsiveness

Adventure Seeking

  

Baseline

Follow-up

CI

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

2.46 (0.55)

2.47 (0.53)

−0.13 – 0.28

2.33 (0.52)

2.25 (0.51)

−0.07 – 0.23

2.50 (0.58)

2.38 (0.61)

10.04–0.29

 

Control

1.87 (0.47)

1.82 (0.44)

−0.04 – 0.11

2.30 (0.46)

2.19 (0.47)

0.02–0.20

2.53 (0.52)

2.39 (0.51)

0.07–0.22

ALL

Men

2.06 (0.61)

2.02 (0.58)

−0.06 – 0.16

2.23 (0.47)

2.15 (0.47)

−0.01 – 0.17

2.57 (0.58)

2.42 (0.56)

0.06–0.25

 

Women

2.04 (0.46)

2.05 (0.53)

−0.07 – 0.15

2.48 (0.45)

2.34 (0.49)

0.01–0.28

2.42 (0.43)

2.33 (0.50)

−0.01 – 0.21

PATIENT

Men

2.48 (0.60)

2.52 (0.46)

−0.18 – 0.33

2.28 (0.51)

2.21 (0.52)

−0.12 – 0.24

2.52 (0.62)

2.34 (0.65)

−0.02 – 0.38

 

Women

2.36 (0.38)

2.30 (0.76)

−0.21 – 0.35

2.52 (0.51)

2.38 (0.48)

−0.22 – 0.49

2.46 (0.39)

2.54 (0.46)

−0.33 – 0.19

CONTROL

Men

1.81 (0.47)

1.72 (0.41)

−0.06 – 0.13

2.19 (0.44)

2.11 (0.44)

−0.02 – 0.20

2.61 (0.55)

2.47 (0.51)

0.04–0.24

 

Women

1.96 (0.45)

1.98 (0.44)

−0.09 – 0.16

2.47 (0.44)

2.33 (0.50)

−0.00 – 0.30

2.41 (0.44)

2.27 (0.50)

0.02–0.27

  

Detachment

Social Desirability

Embitterment

  

Baseline

Follow-up

CI

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

2.77 (0.53)

2.83 (0.45)

−0.14 – 0.17

2.77 (0.53)

2.83 (0.45)

−0.24 – 0.13

2.23 (0.50)

2.22 (0.55)

−0.15 – 0.17

 

Control

2.83 (0.37)

2.92 (0.35)

−0.02 – 0.12

2.83 (0.37)

2.92 (0.35)

−0.15 - -0.03

1.60 (0.41)

1.47 (0.40)

0.05–0.20

ALL

Men

2.80 (0.43)

2.88 (0.39)

−0.05 – 0.12

2.80 (0.43)

2.88 (0.39)

−0.16 – 0.00

1.82 (0.52)

1.72 (0.59)

0.01–0.20

 

Women

2.82 (0.42)

2.90 (0.38)

−0.09 – 0.18

2.82 (0.42)

2.90 (0.38)

−0.21 – 0.06

1.75 (0.56)

1.69 (0.59)

−0.06 – 0.18

PATIENT

Men

2.82 (0.56)

2.80 (0.46)

−0.14 – 0.20

2.82 (0.56)

2.80 (0.46)

−0.18 – 0.21

2.23 (0.44)

2.23 (0.57)

−0.20 – 0.20

 

Women

2.61 (0.42)

2.91 (0.44)

−0.51 – 0.48

2.61 (0.42)

2.91 (0.44)

−0.87 – 0.26

2.23 (0.69)

2.17 (0.51)

−0.22 – 0.34

CONTROL

Men

2.79 (0.34)

2.93 (0.34)

−0.05 – 0.13

2.79 (0.34)

2.93 (0.34)

−0.21 - − 0.07

1.58 (0.39)

1.42 (0.34)

0.08–0.25

 

Women

2.88 (0.41)

2.90 (0.36)

-0.07 – 0.20

2.88 (0.41)

2.90 (0.36)

−0.12 – 0.09

1.62 (0.45)

1.56 (0.47)

−0.08 – 0.20

  

Trait Irritability

Mistrust

  
  

Baseline

Follow-up

CI

Baseline

Follow-up

CI

  

ALL

Patient

2.35 (0.57)

2.13 (0.57)

0.03–0.40

2.26 (0.58)

2.26 (0.52)

−0.13 – 0.15

  
 

Control

2.21 (0.48)

2.03 (0.49)

0.09–0.26

1.75 (0.50)

1.60 (0.47)

0.06–0.24

  

ALL

Men

2.26 (0.49)

2.04 (0.53)

0.12–0.31

1.97 (0.56)

1.86 (0.57)

0.02–0.21

  
 

Women

2.24 (0.55)

2.11 (0.50)

−0.03 – 0.29

1.81 (0.59)

1.72 (0.58)

−0.03 – 0.21

  

PATIENT

Men

2.36 (0.56)

2.16 (0.53)

0.01–0.38

2.28 (0.58)

2.25 (0.53)

−0.14 – 0.21

  
 

Women

2.32 (0.66)

2.04 (0.74)

−0.37 – 0.94

2.20 (0.62)

2.29 (0.55)

−0.24 – 0.07

  

CONTROL

Men

2.20 (0.45)

1.97 (0.51)

0.11–0.34

1.79 (0.47)

1.62 (0.47)

0.05–0.28

  
 

Women

2.22 (0.48)

2.13 (0.43)

−0.05 – 0.22

1.70 (0.54)

1.56 (0.49)

−0.01 -0.29

  
  

Verbal Trait Aggression

Physical Trait Aggression

  
  

Baseline

Follow-up

CI

Baseline

Follow-up

CI

  

ALL

Patient

2.01 (0.64)

2.00 (0.55)

−0.19 – 0.20

1.71 (0.57)

1.84 (0.60)

−0.31 – 0.07

  
 

Control

2.15 (0.47)

1.96 (0.46)

0.10–0.28

1.93 (0.57)

1.67 (0.54)

0.17–0.35

  

ALL

Men

2.12 (0.53)

2.02 (0.58)

−0.01 – 0.21

1.92 (0.60)

1.81 (0.59)

0.00–0.23

  
 

Women

2.07 (0.55)

1.88 (0.43)

0.04–0.33

1.73 (0.53)

1.55 (0.46)

0.01–0.33

  

PATIENT

Men

2.03 (0.62)

2.07 (0.58)

−0.26 – 0.18

1.76 (0.59)

1.86 (0.66)

−0.33 – 0.13

  
 

Women

1.95 (0.74)

1.79 (0.38)

−0.37 – 0.69

1.54 (0.47)

1.74 (0.39)

−0.57 – 0.16

  

CONTROL

Men

2.18 (0.46)

2.00 (0.48)

0.07–0.31

2.02 (0.58)

1.78 (0.55)

0.14–0.35

  
 

Women

2.10 (0.50)

1.91 (0.44)

0.04–0.34

1.78 (0.54)

1.50 (0.47)

0.11–0.44

  
  1. Data is shown by diagnosis (patient vs control) in all subjects, gender in all subjects, gender among patients and gender among controls
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us